-
Full Article (HTML) (145) -
Full Article (PDF) (53) -
Send to Friends (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7245)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 7, 2015 (publication date) through May 20, 2022
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Song MJ. Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3843-3849 [PMID: 25852268 DOI: 10.3748/wjg.v21.i13.3843] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i13/3843.htm |
| Number | Citing Articles |
| 1 |
Jui-Hu Hsiao, Cheng-Chung Tsai, Tsung-Jung Liang, Chia-Ling Chiang, Huei-Lung Liang, I-Shu Chen, Yu-Chia Chen, Po-Ming Chang, Nan-Hua Chou, Being-Whey Wang. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatment. International Journal of Surgery 2017; 45: 35 doi: 10.1016/j.ijsu.2017.07.071
|
| 2 |
Sadahisa Ogasawara, Keisuke Koroki, Hiroaki Kanzaki, Kazufumi Kobayashi, Soichiro Kiyono, Masato Nakamura, Naoya Kanogawa, Tomoko Saito, Takayuki Kondo, Ryo Nakagawa, Shingo Nakamoto, Ryosuke Muroyama, Tetsuhiro Chiba, Naoya Kato. Changes in therapeutic options for hepatocellular carcinoma in Asia. Liver International 2021; doi: 10.1111/liv.15101
|
| 3 |
Wenbo Guo, Jian Gao, Wenquan Zhuang, Zhiqiang Wu, Bin Li, Song Chen. Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score‐matching cohort study. JGH Open 2020; 4(3): 477 doi: 10.1002/jgh3.12285
|
| 4 |
Wei-Lun Tsai, Wei-Chi Sun, Wen-Chi Chen, Chia-Ling Chiang, Huey-Shyan Lin, Huei-Lung Liang, Jin-Shiung Cheng. Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma. Medicine 2020; 99(32): e21489 doi: 10.1097/MD.0000000000021489
|
| 5 |
Wen-Tsan Chang, Yung-Ding Bow, Pei-Jung Fu, Chia-Yang Li, Chang-Yi Wu, Yi-Hua Chang, Yen-Ni Teng, Ruei-Nian Li, Mei-Chin Lu, Yi-Chang Liu, Chien-Chih Chiu, Cristina Angeloni. A Marine Terpenoid, Heteronemin, Induces Both the Apoptosis and Ferroptosis of Hepatocellular Carcinoma Cells and Involves the ROS and MAPK Pathways. Oxidative Medicine and Cellular Longevity 2021; 2021: 1 doi: 10.1155/2021/7689045
|
| 6 |
Min Kyu Kang, Jung Gil Park, Heon Ju Lee. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma. Medicine 2018; 97(17): e0611 doi: 10.1097/MD.0000000000010611
|
| 7 |
Lipika Goyal, Motaz Qadan, Andrew X. Zhu. Another Treatment Option for Advanced Hepatocellular Carcinoma With Portal Vein Thrombosis in China. JAMA Oncology 2019; 5(7): 938 doi: 10.1001/jamaoncol.2019.0249
|
| 8 |
Michael Hsu, Muneeb Ahmed, Ammar Sarwar. Indications and Best Practices for Intra-arterial Therapies to Treat Hepatocellular Carcinoma. Current Hepatology Reports 2018; 17(4): 399 doi: 10.1007/s11901-018-0428-4
|
| 9 |
Jaejun Lee, Pil Soo Sung, Hyun Yang, Soon Kyu Lee, Hee Chul Nam, Sun Hong Yoo, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Jung Hyun Kwon, Jeong Won Jang, Chang Wook Kim, Soon Woo Nam, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon. A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC. Journal of Clinical Medicine 2020; 9(12): 4121 doi: 10.3390/jcm9124121
|
| 10 |
Ying Liu, Yuzhu Wang, Xinkun Guo, Yifeng He, Jian Zhou, Qianzhou Lv, Xiaowu Huang, Xiaoyu Li. Comparative Effectiveness of Adjuvant Treatment for Resected Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.709278
|
| 11 |
A.H.K. Abdelmaksoud, A.O. Abdelaziz, M.M. Nabeel, I. Hamza, T.M. Elbaz, H.I. Shousha, R.S.M. Abdelhady, R. Lithy. Hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein thrombosis: a case–control study. Clinical Radiology 2021; 76(9): 709.e1 doi: 10.1016/j.crad.2021.03.022
|
| 12 |
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Cancer Chemotherapy and Pharmacology 2018; 82(3): 469 doi: 10.1007/s00280-018-3638-0
|
| 13 |
Hee Chul Nam, Pil Soo Sung, Ho Jong Chun, Dong Goo Kim, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon. Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Journal of Liver Cancer 2019; 19(1): 64 doi: 10.17998/jlc.19.1.64
|
| 14 |
Mahmoud Aryan, Ellery Altshuler, Xia Qian, Wei Zhang. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach [Working Title]. 2021; doi: 10.5772/intechopen.99837
|
| 15 |
Minhyung Kim, Colin A. Powers, Leslie I. Curtin, Daniel T. Fisher, Sandra Sexton, Katerina V. Gurova, Joseph J. Skitzki, Renuka V. Iyer. A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks. Journal of Surgical Research 2020; 251: 126 doi: 10.1016/j.jss.2020.02.002
|
| 16 |
Di Ma, Juan Wang, Lu Liu, Meiqi Chen, Zhiyong Wang. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07447-3
|
| 17 |
Masafumi Ikeda, Takuji Okusaka, Yozo Sato, Junji Furuse, Shuichi Mitsunaga, Hideki Ueno, Chigusa Morizane, Yoshitaka Inaba, Tatsushi Kobayashi, Yasuaki Arai. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinoma. Japanese Journal of Clinical Oncology 2017; 47(6): 512 doi: 10.1093/jjco/hyx038
|
| 18 |
Elena Fountzilas, Elangovan Krishnan, Filip Janku, Siqing Fu, Daniel D. Karp, Aung Naing, Vivek Subbiah, David S. Hong, Sarina A. Piha-Paul, David J. Vining, Apostolia-Maria Tsimberidou. A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvement. Cancer Chemotherapy and Pharmacology 2018; 82(5): 877 doi: 10.1007/s00280-018-3680-y
|
| 19 |
Hong Liu, Yiyang Xu, Jingyi Xiang, Li Long, Shon Green, Zhiyuan Yang, Bryan Zimdahl, Jingwei Lu, Neal Cheng, Lucas H. Horan, Bin Liu, Su Yan, Pei Wang, Juan Diaz, Lu Jin, Yoko Nakano, Javier F. Morales, Pengbo Zhang, Lian-xing Liu, Binnaz K. Staley, Saul J. Priceman, Christine E. Brown, Stephen J. Forman, Vivien W. Chan, Cheng Liu. Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer. Clinical Cancer Research 2017; 23(2): 478 doi: 10.1158/1078-0432.CCR-16-1203
|
| 20 |
Ziyou Wang, Hua Zhang, Jiahui Zhou, Xiangning Zhang, Liyong Chen, Kangxing Chen, Zunnan Huang. Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle. Cancer Chemotherapy and Pharmacology 2016; 78(6): 1143 doi: 10.1007/s00280-016-3171-y
|
| 21 |
Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver Tumors. Cancers 2019; 11(4): 581 doi: 10.3390/cancers11040581
|
| 22 |
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
|
| 23 |
Xiao-long Wu, Ying Chen, Wen-cui Kong, Zhong-quan Zhao. Amyloid precursor protein regulates 5-fluorouracil resistance in human hepatocellular carcinoma cells by inhibiting the mitochondrial apoptotic pathway. Journal of Zhejiang University-SCIENCE B 2020; 21(3): 234 doi: 10.1631/jzus.B1900413
|
| 24 |
Kazuya SASAKI, Toshiki SAKAMOTO, So MATSUI, Misao SAITO. Multiple Early Intrahepatic Recurrences of Hepatocellular Carcinoma after Hepatectomy Successfully Treated by Hepatic Arterial Chemotherapy. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2018; 79(7): 1506 doi: 10.3919/jjsa.79.1506
|
| 25 |
Taro Takami, Takahiro Yamasaki, Issei Saeki, Toshihiko Matsumoto, Yutaka Suehiro, Isao Sakaida. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function. World Journal of Gastroenterology 2016; 22(32): 7252-7263 doi: 10.3748/wjg.v22.i32.7252
|
| 26 |
Fangmin Chen, Yifan Fang, Ruirui Zhao, Jingqing Le, Bingchen Zhang, Rui Huang, Zixuan Chen, Jingwei Shao. Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma. European Journal of Medicinal Chemistry 2019; 179: 916 doi: 10.1016/j.ejmech.2019.06.070
|
| 27 |
Shousheng Liu, Jinfa Lai, Ning Lyu, Qiankun Xie, Huijiao Cao, Dabiao Chen, Meng He, Bei Zhang, Ming Zhao. Effects of Antiviral Therapy on HBV Reactivation and Survival in Hepatocellular Carcinoma Patients Undergoing Hepatic Artery Infusion Chemotherapy. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.582504
|
| 28 |
Iveta Urban, Florian Primavesi, Klaus Bogner, Claudia Bartsch, Marlene Trattner, Alexandra Schmid, Stefan Stättner. Hepatocellular carcinoma—neoadjuvant systemic and local treatment concepts to improve resectability rates and oncological outcome. memo - Magazine of European Medical Oncology 2022; 15(1): 5 doi: 10.1007/s12254-021-00791-5
|